Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia in Remission

Explore clinical trials studying Acute Myeloid Leukemia in Remission. Study availability and eligibility vary by location and protocol.

26 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia in Remission trial results

Recruiting

Ziftomenib Maintenance Post Allo-HCT

NCT06440135

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Hematologic Diseases, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Ohio State University Wexner Medical Center- James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

NCT05917405

Conditions
Acute Myeloid Leukemia in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU de Nantes Nantes, Loire Atlantique, France
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CHU Besançon Besançon, France
View all 23 locations
View Trial Details
Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

NCT06462365

Conditions
Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, Adult T-Cell, Acute Myeloid Leukemia in Remission, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions
Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • AZ Sint Jan Brugge Bruges, Belgium
  • IJ Bordet Brussels, Belgium
  • UZ Brussel Brussels, Belgium
View Trial Details
Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions